Monday, February 22, 2016

Why Valeant Pharmaceuticals can Crash on Q4 Earnings Report

Bidness ETC-1 hour ago
... highlighting the impact of sales that would have earlier been generated by its controversial mail-order pharmacy, Phili

No comments: